Financhill
Back

Voya Global Advantage and Premium Opportunity Fund Vs. Novo Nordisk AS Industry Stock Comparison

Buy
59

IGA
Voya Global Advantage and Premium Opportunity Fund

Last Price:
$9.58
Seasonality Move:
0.94%
Sell
30

NONOF
Novo Nordisk AS

Last Price:
$74.16
Seasonality Move:
4.87%
Buy
59
Voya Global Advantage and Premium Opportunity Fund (IGA) is a Buy

Is Voya Global Advantage and Premium Opportunity Fund a Buy, Sell or Hold?

  • The current Voya Global Advantage and Premium Opportunity Fund [IGA] share price is $9.57. The Score for IGA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • IGA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $79.09. The Score for NONOF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IGA Stock Price Chart

What is Voya Global Advantage and Premium Opportunity Fund's stock price today?

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $79.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

IGA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 48.05 Sell
Chaikin Money Flow: -13032 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.45 - 9.71) Sell
Bollinger Bands (100): (9.33 - 9.63) Buy

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 38.5 Sell
Chaikin Money Flow: 404837 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (81.79 - 89.61) Sell
Bollinger Bands (100): (83.94 - 109.78) Sell

IGA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.66 Sell
20-day SMA: 9.64 Sell
50-day SMA: 9.48 Buy
200-day SMA: 9.3 Buy
8-day EMA: 9.64 Sell
20-day EMA: 9.62 Sell
50-day EMA: 9.54 Buy
200-day EMA: 9.3 Buy

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.84 Sell
20-day SMA: 85.93 Sell
50-day SMA: 85.07 Sell
200-day SMA: 115.26 Sell
8-day EMA: 86.5 Sell
20-day EMA: 86.55 Sell
50-day EMA: 88.81 Sell
200-day EMA: 104.91 Sell

Voya Global Advantage and Premium Opportunity Fund Earnings Growth & IGA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.

Voya Global Advantage and Premium Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):